Copyright
©The Author(s) 2023.
World J Gastrointest Pathophysiol. Mar 22, 2023; 14(2): 21-33
Published online Mar 22, 2023. doi: 10.4291/wjgp.v14.i2.21
Published online Mar 22, 2023. doi: 10.4291/wjgp.v14.i2.21
Number of case-control pairs according to serum anti-OV status: positive (+) vs negative (-) | Crude OR | 95%CI | P value | Adjusted1 OR | 95%CI | P value | Adjusted2 OR | 95%CI | P value | ||||||
Case (+) / Control (+) | Case (+) / Control (-) | Case (-) / Control (+) | Case (-) / Control (-) | LL | UL | LL | UL | LL | UL | ||||||
67 | 23 | 2 | 3 | 11.50 | 2.71 | 48.78 | < 0.001 | 8.96 | 2.06 | 38.99 | 0.001 | 9.40 | 2.16 | 40.85 | 0.003 |
- Citation: You G, Zeng L, Tanaka H, Ohta E, Fujii T, Ohshima K, Tanaka M, Hamajima N, Viwatthanasittiphong C, Muangphot M, Chenvidhya D, Jedpiyawongse A, Sripa B, Miwa M, Honjo S. Polymorphism of genes encoding drug-metabolizing and inflammation-related enzymes for susceptibility to cholangiocarcinoma in Thailand. World J Gastrointest Pathophysiol 2023; 14(2): 21-33
- URL: https://www.wjgnet.com/2150-5330/full/v14/i2/21.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v14.i2.21